GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
U

Unichem Laboratories UNICHEMLAB.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

509.15

+1.48%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2025

Revenue

₹21.11bn

FY2016FY2025

Net income

₹1.38bn

FY2016FY2025

Free cash flow

−₹1.45bn

FY2016FY2025

Shareholders' equity

₹24.51bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₹21.11bn₹17.85bn₹13.43bn₹12.70bn₹12.35bn₹12.11bn₹11.80bn₹8.15bn₹6.99bn₹13.48bn
Gross profit₹11.39bn₹9.41bn₹6.70bn₹7.51bn₹7.65bn₹7.28bn₹6.36bn₹3.94bn₹4.39bn₹8.18bn
Research and development————————₹585.3m₹416.3m
Operating income₹1.40bn−₹971.1m−₹1.93bn−₹132.7m₹72.8m−₹1.31bn−₹1.42bn−₹1.78bn−₹840.7m₹1.22bn
Net income₹1.38bn−₹937.6m−₹2.02bn₹330.6m₹343.2m−₹601.8m−₹238.0m₹25.45bn₹1.09bn₹1.08bn
Diluted earnings per share19.50-13.27-28.734.704.88-8.55-3.38361.5415.4415.35

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₹35.69bn₹32.75bn₹31.93bn₹33.19bn₹31.26bn₹31.45bn₹31.50bn₹31.94bn₹15.27bn₹12.84bn
Cash and short-term investments₹1.17bn₹1.58bn₹1.85bn₹3.76bn₹3.17bn₹6.51bn₹9.99bn₹15.64bn₹217.5m₹250.6m
Total liabilities₹11.19bn₹8.37bn₹7.58bn₹7.00bn₹5.69bn₹6.13bn₹5.30bn₹5.14bn₹4.63bn₹3.29bn
Debt₹4.26bn₹2.18bn₹2.83bn₹3.19bn₹1.15bn₹2.02bn₹2.00bn₹1.51bn₹980.6m₹359.1m
Shareholders' equity₹24.51bn₹24.38bn₹24.35bn₹26.18bn₹25.57bn₹25.31bn₹26.20bn₹26.80bn₹10.64bn₹9.54bn
Shares outstanding71m71m70m70m70m70m70m70m70m70m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−₹77.0m₹269.1m−₹469.6m−₹2.60bn₹406.9m₹198.2m−₹3.28bn−₹1.12bn₹681.9m₹1.12bn
Capital spending−₹1.37bn−₹225.5m−₹443.2m−₹1.27bn−₹2.88bn−₹3.86bn−₹1.94bn−₹1.60bn−₹1.50bn−₹1.62bn
Free cash flow−₹1.45bn₹43.6m−₹912.7m−₹3.87bn−₹2.47bn−₹3.66bn−₹5.22bn−₹2.72bn−₹816.5m−₹498.6m
Dividends paid−₹3.4m−₹2.1m−₹282.5m−₹283.6m−₹286.6m−₹340.3m−₹423.5m−₹329.7m−₹7.0m−₹433.3m

Latest quarters

By quarter end

Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024
Revenue₹5.21bn₹5.79bn₹5.27bn₹5.87bn₹5.33bn₹4.62bn₹4.46bn₹4.32bn
Gross profit₹2.84bn₹3.09bn₹2.82bn₹3.23bn₹3.42bn₹2.88bn₹2.86bn₹2.65bn
Operating income₹135.3m−₹235.5m−₹93.0m₹540.1m₹549.8m₹289.9m₹151.7m−₹18.0m
Net income₹2.64bn−₹118.9m−₹104.7m₹529.7m₹578.5m₹304.9m₹92.6m−₹1.29bn
Diluted earnings per share37.47-1.69-1.487.518.194.321.31-18.34
Cash from operations—₹1.00bn—−₹77.0m—₹454.0m—₹269.0m
Capital spending—−₹586.0m—−₹1.37bn—−₹425.0m—−₹225.0m
Free cash flow—₹415.0m—−₹1.45bn—₹29.0m—₹44.0m
Total assets—₹35.56bn—₹35.69bn—₹33.11bn—₹31.69bn
Cash and short-term investments—₹1.94bn—₹1.17bn—₹1.98bn—₹1.54bn
Debt—₹671.3m—₹4.26bn—₹514.5m—₹2.18bn
Shareholders' equity—₹24.35bn—₹24.51bn—₹24.01bn—₹23.62bn

Financial ratios

Data as of 23 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin30.0%59.1%19.2%59.8%64.3%65.4%—
Operating margin2.7%40.0%-2.4%-12.0%2.2%4.7%—
Net margin11.5%6.5%-4.3%-15.3%2.6%2.8%—
Return on equity9.3%5.6%-3.0%-8.3%1.3%1.3%—
Return on assets6.8%3.9%-2.2%-6.3%1.0%1.1%—
Free cash flow yield2.7%3.2%0.9%-1.0%-3.3%8.0%—
Revenue growth4.3%27.4%25.0%5.6%4.2%4.2%—
Earnings growth83.9%-295.1%-65.2%-711.7%-3.7%-157.0%—
Current ratio2.48x2.05x2.39x2.48x2.98x2.72x—
Debt to equity0.17x0.18x0.09x0.12x0.13x0.04x—
Equity ratio72.7%68.7%74.5%76.3%78.9%81.8%—
Interest coverage1.87x40.18x-1.72x-9.19x4.60x11.26x—
R&D as a share of sales—0.9%6.3%8.3%9.0%10.8%13.5%
Buybacks as a share of market value0.2%0.1%-0.3%0.0%0.0%0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue18.5%11.8%5.8%
Operating income——8.8%
Net income60.8%—6.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin53.4%53.8%55.8%56.5%
Operating margin1.1%-2.5%-3.2%-3.6%
Net margin1.1%-1.9%-1.7%18.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings22.7-56.0-14.167.251.0-30.7-47.30.521.416.7
Price to sales1.52.92.11.81.41.50.91.63.31.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 22 Jul 2021.

FY2022FY2021FY2020FY2019FY2018FY2016FY2015FY2014
Paid in the year4.004.004.005.003.004.004.008.50
  • 2.5-for-1 split · 21 Oct 2010
  • 4-for-1 split · 17 Mar 2004
  • 2-for-1 split · 3 Apr 2000

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.